Literature DB >> 17653693

Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells.

Caroline Henrike Storch1, Hans-Dieter Klimm, Tilman Heinrich, Walter Emil Haefeli, Johanna Weiss.   

Abstract

Several studies have demonstrated that the adenosine triphosphate-binding cassette transporter P-glycoprotein (P-gp) is at least partly located in cholesterol- and sphingolipid-enriched parts of the plasma membrane called "lipid rafts" and that modification of cellular cholesterol content has an impact on the activity of P-gp in vitro and ex vivo. Cholesterol modulation in vitro does not closely reflect the in vivo situation. The aim of our study was therefore to investigate whether differences in individual plasma low-density lipoprotein (LDL) cholesterol levels in humans have an impact on cholesterol content in peripheral blood mononuclear cells (PBMCs) and thereby on individual activity of P-gp. PBMCs of 20 ambulatory patients with elevated LDL cholesterol (173.9 +/- 22.4 mg/dl; range 151.0-234.4 mg/dl) and 28 controls (125.2 +/- 16.9 mg/dl; range 74.6-149.6 mg/dl) were isolated. Cellular cholesterol was measured by an enzymatic fluorimetric assay, efflux activity of P-gp in PBMCs was determined by a flow cytometric method (rhodamine123 efflux), and messenger ribonucleic acid expression was quantified by reverse transcriptase real-time polymerase chain reaction (RT-PCR). There was no difference in cellular cholesterol or P-gp activity between the two groups suggesting that high plasma LDL cholesterol concentration as observed in dyslipidemic patients does not correlate with cellular cholesterol content or P-gp activity in PBMCs. There was, however, a significant negative relationship between age and P-gp efflux activity indicating that P-gp activity in PBMCs decreases with advancing age. These results need further confirmation because investigation of age dependency of P-gp activity was not the primary aim of the study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653693     DOI: 10.1007/s00210-007-0177-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Rapid detection of the C3435T polymorphism of multidrug resistance gene 1 using fluorogenic hybridization probes.

Authors:  M Nauck; U Stein; S von Karger; W März; H Wieland
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

2.  Age-related changes of the multidrug resistance P-glycoprotein function in normal human peripheral blood T lymphocytes.

Authors:  C G Machado; R T Calado; A B Garcia; R P Falcão
Journal:  Braz J Med Biol Res       Date:  2003-11-17       Impact factor: 2.590

Review 3.  Lipid rafts, detergent-resistant membranes, and raft targeting signals.

Authors:  Deborah A Brown
Journal:  Physiology (Bethesda)       Date:  2006-12

4.  Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.

Authors:  Edna F Choo; Daniel Kurnik; Mordechai Muszkat; Tadashi Ohkubo; Sheila D Shay; James N Higginbotham; Hartmut Glaeser; Richard B Kim; Alastair J J Wood; Grant R Wilkinson
Journal:  J Pharmacol Exp Ther       Date:  2006-03-14       Impact factor: 4.030

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 6.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06

7.  Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines.

Authors:  Loukas Tatidis; Michèle Masquelier; Sigurd Vitols
Journal:  Biochem Pharmacol       Date:  2002-06-15       Impact factor: 5.858

8.  Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells.

Authors:  Joachim Troost; Heike Lindenmaier; Walter Emil Haefeli; Johanna Weiss
Journal:  Mol Pharmacol       Date:  2004-08-12       Impact factor: 4.436

9.  Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells.

Authors:  Joachim Troost; Nadine Albermann; Walter Emil Haefeli; Johanna Weiss
Journal:  Biochem Biophys Res Commun       Date:  2004-04-09       Impact factor: 3.575

10.  Validation of using gene expression in mononuclear cells as a marker for hepatic cholesterol metabolism.

Authors:  Dimple Aggarwal; Hedley C Freake; Ghada A Soliman; Amrita Dutta; Maria-Luz Fernandez
Journal:  Lipids Health Dis       Date:  2006-08-15       Impact factor: 3.876

View more
  1 in total

1.  Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate.

Authors:  Vânia Vilas-Boas; Renata Silva; Andreia Palmeira; Emília Sousa; Luísa Maria Ferreira; Paula Sério Branco; Félix Carvalho; Maria de Lourdes Bastos; Fernando Remião
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.